Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Long-term prognosis of adults with moderate-severe SARS-CoV-2 lower respiratory tract infection managed in primary care: prospective cohort study

T.N. Platteel, J.C. Koelmans, D. Cianci, N.J.H. Broers, E.G.P.M. de Bont, J.W.L. Cals, R.P. Venekamp, T.J.M. Verheij
doi: https://doi.org/10.1101/2022.06.07.22276108
T.N. Platteel
1Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: T.N.Platteel-3{at}umcutrecht.nl
J.C. Koelmans
1Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
D. Cianci
1Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
N.J.H. Broers
2Department of Family Medicine, Care and Public Health Research Institute (CAPHRI), Maastricht University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
E.G.P.M. de Bont
2Department of Family Medicine, Care and Public Health Research Institute (CAPHRI), Maastricht University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J.W.L. Cals
2Department of Family Medicine, Care and Public Health Research Institute (CAPHRI), Maastricht University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
R.P. Venekamp
1Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
T.J.M. Verheij
1Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Objectives To determine differences in health-related quality of life (HRQoL) and presence and duration of symptoms between adults with and without established SARS-CoV-2 moderately severe lower respiratory tract infection (LRTI) in the 12 months following their primary care visit.

Design Prospective cohort study

Setting 35 general practices in the provinces Noord-Brabant and Utrecht, the Netherlands.

Participants Individuals aged ≥18 years who presented to their general practitioner (GP) with a moderately severe LRTI during the first COVID-19 waive in The Netherlands (March-June 2021) underwent serology testing (participants, GPs and study personnel remained blinded for serology outcomes during study conduct) and completed baseline and follow-up questionnaires. Of the 315 participants who gave consent, 277 (88%) were suitable for inclusion in the analyses. Complete follow-up date was available in 97% of participants.

Main outcome measures 1) Scores of SF-36; physical component summary (PCS), mental component summary (MCS) and subscales. 2) Risk of any and individual persisting symptoms (of cough, dyspnea, chest pain, fatigue, brain fog, headache, and anosmia/ageusia) over time.

Results The change in SF-36 PSC (p=0.13), MCS (p=0.30), as well as subscale scores, over time did not differ between SARS-CoV-2 serology positive and negative participants after adjusting for sex, age, BMI, diabetes and chronic pulmonary conditions. The risk of any persisting symptom over time did not significantly differ between the groups (aHR 0.61, 95% CI 0.33-1.15), nor did the risk of individual symptoms.

Conclusions In the 12 months following their moderately severe LRTI, primary care patients with and without confirmed SARS-CoV-2 infection had a comparable HRQoL profile. Albeit a considerable proportion of patients reported persistent symptoms, there was no evidence of a difference in the course of symptoms over time between patients with and without confirmed SARS-CoV-2 infection.

Trial registration Dutch Trial Register (NTR) number NL8729

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This study was funded by ZonMw

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Ethics committee of the University Medical Center Utrecht gave ethical approval for this work

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • Email addresses:

  • T.N. Platteel: T.N.Platteel-3{at}umcutrecht.nl,

  • J.C. Koelmans: J.C.Koelmans{at}umcutrecht.nl

  • D. Cianci: D.Cianci{at}umcutrecht.nl

  • N.J.H. Broers: N.Broers{at}maastrichtuniversity.nl

  • E.G.P.M. de Bont: Eefje.debont{at}maastrichtuniversity.nl

  • J.W.L. Cals: J.Cals{at}maastrichtuniversity.nl

  • R.P. Venekamp: R.P.Venekamp{at}umcutrecht.nl

  • T.J.M. Verheij: T.J.M.Verheij{at}umcutrecht.nl

Data Availability

All data produced in the present study are available upon reasonable request to the authors

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted June 08, 2022.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Long-term prognosis of adults with moderate-severe SARS-CoV-2 lower respiratory tract infection managed in primary care: prospective cohort study
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Long-term prognosis of adults with moderate-severe SARS-CoV-2 lower respiratory tract infection managed in primary care: prospective cohort study
T.N. Platteel, J.C. Koelmans, D. Cianci, N.J.H. Broers, E.G.P.M. de Bont, J.W.L. Cals, R.P. Venekamp, T.J.M. Verheij
medRxiv 2022.06.07.22276108; doi: https://doi.org/10.1101/2022.06.07.22276108
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Long-term prognosis of adults with moderate-severe SARS-CoV-2 lower respiratory tract infection managed in primary care: prospective cohort study
T.N. Platteel, J.C. Koelmans, D. Cianci, N.J.H. Broers, E.G.P.M. de Bont, J.W.L. Cals, R.P. Venekamp, T.J.M. Verheij
medRxiv 2022.06.07.22276108; doi: https://doi.org/10.1101/2022.06.07.22276108

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (430)
  • Allergy and Immunology (754)
  • Anesthesia (221)
  • Cardiovascular Medicine (3286)
  • Dentistry and Oral Medicine (363)
  • Dermatology (277)
  • Emergency Medicine (479)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1169)
  • Epidemiology (13352)
  • Forensic Medicine (19)
  • Gastroenterology (898)
  • Genetic and Genomic Medicine (5142)
  • Geriatric Medicine (481)
  • Health Economics (782)
  • Health Informatics (3263)
  • Health Policy (1140)
  • Health Systems and Quality Improvement (1189)
  • Hematology (429)
  • HIV/AIDS (1016)
  • Infectious Diseases (except HIV/AIDS) (14618)
  • Intensive Care and Critical Care Medicine (912)
  • Medical Education (476)
  • Medical Ethics (126)
  • Nephrology (522)
  • Neurology (4916)
  • Nursing (262)
  • Nutrition (725)
  • Obstetrics and Gynecology (882)
  • Occupational and Environmental Health (795)
  • Oncology (2518)
  • Ophthalmology (723)
  • Orthopedics (280)
  • Otolaryngology (347)
  • Pain Medicine (323)
  • Palliative Medicine (90)
  • Pathology (542)
  • Pediatrics (1299)
  • Pharmacology and Therapeutics (549)
  • Primary Care Research (556)
  • Psychiatry and Clinical Psychology (4201)
  • Public and Global Health (7492)
  • Radiology and Imaging (1704)
  • Rehabilitation Medicine and Physical Therapy (1010)
  • Respiratory Medicine (980)
  • Rheumatology (479)
  • Sexual and Reproductive Health (497)
  • Sports Medicine (424)
  • Surgery (547)
  • Toxicology (72)
  • Transplantation (235)
  • Urology (204)